Ipilimumab-refractory advanced melanoma: Pembrolizumab ... Ipilimumab-refractory advanced melanoma: Pembrolizumab, an anti-PD-1 antibody, shows efficacy. The anti-programmed-death-receptor-1 ( PD-1 ) antibody ...Opdivo for the treatment of squamous non-small cell lung ... Opdivo for the treatment of squamous non-small cell lung cancer. The FDA ( Food and Drug Administration ) has expanded the approved use of Opdivo ...Non-small cell lung cancer harboring wild-type EGFR ... Non-small cell lung cancer harboring wild-type EGFR: conventional chemotherapy, compared with first-generation EGFR TKI, is associated with improvement in ...
Oncology Newsletter
Ipilimumab-refractory advanced melanoma: Pembrolizumab ... Ipilimumab-refractory advanced melanoma: Pembrolizumab, an anti-PD-1 antibody, shows efficacy. The anti-programmed-death-receptor-1 ( PD-1 ) antibody ...Opdivo for the treatment of squamous non-small cell lung ... Opdivo for the treatment of squamous non-small cell lung cancer. The FDA ( Food and Drug Administration ) has expanded the approved use of Opdivo ...Non-small cell lung cancer harboring wild-type EGFR ... Non-small cell lung cancer harboring wild-type EGFR: conventional chemotherapy, compared with first-generation EGFR TKI, is associated with improvement in ...